CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 1.670
-0.060 (-3.47%)
Nov 3, 2026, 3:21 PM HKT
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 997.73 million as of November 2, 2026. It is the 23,302nd most valuable company in the world and the 1,106th biggest in Hong Kong. Its market cap has decreased by 0.85% in one year.
Market Cap
997.73M
Enterprise Value
929.28M
Revenue
64.28M
Global Rank
Country Rank
#1,106 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 997.73M, a decrease of -73.57%. That is a compound annual growth rate of -23.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 997.73M | -23.75% |
| Dec 31, 2025 | 1.31B | 2,215.73% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
| Dec 10, 2021 | 3.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Biostar Pharmaceuticals | 1.44B |
| PegBio | 1.44B |
| SinoMab BioScience | 1.41B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.24B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.21B |
| Cloudbreak Pharma | 1.10B |
| TYK Medicines | 1.10B |
| Zhaoke Ophthalmology | 1.09B |